Doctor Francesco Santoro

Doctor Francesco Santoro

University of Foggia, Foggia (Italy)

Member of:

Francesco Santoro, MD, PhD, is a consultant in cardiology at the University hospital of Foggia, Policlinico Riuniti, Italy. In 2013, he attended for six months Texas Arrhythmia Institute, Austin, Texas, USA under the supervision of Dr. Andrea Natale. Between 2015 and 2018 he attended the electrophysiology laboratory at the Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany. Research topic: Cardiomyopathies (Takotsubo syndrome) and catheter ablation of Atrial Fibrillation and Ventricular Tachycardia (Papillary muscles VT/VF). He authored 180 publications in indexed journals, about 175 abstracts and 6 electrophysiology book chapters.

Presentations Articles

Oral flecainide therapy and myocardial pacing: preliminary data from a prospective multicenter registry

Event: EHRA 2024

Topic: Antibradycardia Pacing

Session: Poster session on devices, others

Access

Immune modulating drugs and oral anticoagulation in kidney transplant recipients: comparison of direct oral anticoagulants versus antagonist of vitamin-k. results from a multicenter prospective study.

Event: EHRA 2023

Topic: Oral Anticoagulation

Session: Atrial Fibrillation - Round 1 - Stroke - OAC

Access

Long-term mayor adverse cardiovascular events after covid-19 infection: a clinical score from a cohort of 2575 patients enrolled in the multicenter international HOPE 2 registry

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: COVID-19 and acute coronary syndromes

Access

Aspirin therapy on prophylactic anticoagulation for hospitalized patients with COVID-19: A propensity score-matched cohort analysis of the HOPE-COVID-19 registry.

Event: ESC Congress 2022

Topic: Anticoagulants

Session: Challenges and advances in antithrombotic therapy

Access

Fever following Covid-19 vaccination in subjects with Brugada syndrome: incidence and management.

Event: EHRA 2022

Topic: Ion Channel Disorders

Session: ePosters Day 3

Access

Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19).

Event: ESC Congress 2021 - The Digital Experience

Topic: Antiplatelet Drugs

Session: COVID-19 and cardiovascular pharmacotherapy

Access

Neoplastic markers in Takotsubo syndrome. Results from a prospective registry.

Event: ESC Congress 2020

Topic: Cardio-Oncology

Session: Cardiovascular Disease in Special Populations ePosters

Access

Prevalence, management and outcome of life-threatening arrhythmias in Takotsubo Syndrome:

Event: EHRA 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Moderated ePosters 4: Understanding the substrate for ventricular arrhythmias

Access

Takotsubo syndrome in patients with malignancies: a metanalysis.

Event: ESC Congress 2018

Topic: Cardio-Oncology

Session: Cardiovascular events in malignancies: from prediction to prevention

Access

In-hospital complications in patients with takotsubo syndrome: a novel score from a cohort of 1002 patients from the multi-center international GEIST registry.

Event: ESC Congress 2018

Topic: Takotsubo Cardiomyopathy

Session: Best Posters in Takotsubo cardiomyopathy

Access

Doctor Francesco Santoro

Biography

Contributor content

Oral flecainide therapy and myocardial pacing: preliminary data from a prospective multicenter registry

Immune modulating drugs and oral anticoagulation in kidney transplant recipients: comparison of direct oral anticoagulants versus antagonist of vitamin-k. results from a multicenter prospective study.

Long-term mayor adverse cardiovascular events after covid-19 infection: a clinical score from a cohort of 2575 patients enrolled in the multicenter international HOPE 2 registry

Aspirin therapy on prophylactic anticoagulation for hospitalized patients with COVID-19: A propensity score-matched cohort analysis of the HOPE-COVID-19 registry.

Fever following Covid-19 vaccination in subjects with Brugada syndrome: incidence and management.

Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19).

Neoplastic markers in Takotsubo syndrome. Results from a prospective registry.

Prevalence, management and outcome of life-threatening arrhythmias in Takotsubo Syndrome:

Takotsubo syndrome in patients with malignancies: a metanalysis.

In-hospital complications in patients with takotsubo syndrome: a novel score from a cohort of 1002 patients from the multi-center international GEIST registry.

ESC 365 is supported by